Skip to Main Content

Paper Details

Third-line therapy for chronic myeloid leukemia: current status and future directions.
J Hematol Oncol
51
2021
Author NameAffiliation
Jorge CortesGeorgia Cancer Center at Augusta University
  • 1 - 1

Datasets

Release 1.2